ARCH.V · Arch Biopartners Inc.
Canada · RS rating 39 · As of 2026-10-14
| Price | 0.83 CAD |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 28 / 48 / 23 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 24 / 25 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +42.8% |
| Market cap (USD) | $39.6M |